Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan.
about
Current state of the art of regional hyperthermia treatment planning: a reviewOverview of bladder heating technology: matching capabilities with clinical requirements.Temperature superposition for fast computation of 3D temperature distributions during optimization and planning of interstitial ultrasound hyperthermia treatments.Simulation techniques in hyperthermia treatment planning.Microwave thermal imaging of scanned focused ultrasound heating: phantom results.Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations.Heating the patient: a promising approach?Benefits of superficial hyperthermia treatment planning: five case studies.The Kadota Fund International Forum 2004--clinical group consensus.Laser Ablation for Cancer: Past, Present and FutureImplementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: an overview and the Rotterdam experience.Miniature microwave applicator for murine bladder hyperthermia studies.Benefit of replacing the Sigma-60 by the Sigma-Eye applicator. A Monte Carlo-based uncertainty analysis.Thermal monitoring: invasive, minimal-invasive and non-invasive approaches.Current devices for high-performance whole-body hyperthermia therapy.Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?Hyperthermia phased arrays pre-treatment evaluation.Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality.Comparison of MR-thermography and planning calculations in phantoms.Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis.Complex difference constrained compressed sensing reconstruction for accelerated PRF thermometry with application to MRI-induced RF heating.Measurement of SAR-induced temperature increase in a phantom and in vivo with comparison to numerical simulation.Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma.Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging.Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models.Simulation of different applicator positions for treatment of a presacral tumour.On verification of hyperthermia treatment planning for cervical carcinoma patients.Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer.Thermal dosimetry for bladder hyperthermia treatment. An overview.Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures.Electric field distributions in a phased-array applicator with 12 channels: measurements and numerical simulations.Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning
P2860
Q26783500-7062FF32-2BE6-489F-A9F0-30F1A8FF7CA3Q30355153-DD77C1FE-27E3-4521-BD75-366010B0B0F2Q30397935-7B956A1F-8DA6-4F3F-A209-5E1261C110A8Q30437539-5C693FE3-07F2-4B21-81B9-70D4A0D8BCE4Q30484047-3305C5A5-4403-4687-B437-03D32B2AFC20Q30639687-D4CFE2C2-E8C0-4FAA-98D3-CF81EE4402D6Q33184112-02A8090F-8D20-4059-B5C3-877100A62F85Q33294300-8B74B933-2D33-4F18-A858-FA619C79B8ADQ33320286-49E7CC2F-741D-43A2-956E-E272A616444AQ33855869-D1D6A1C9-F6D5-4562-9628-BE970CF1C9F1Q34300911-490A8CCF-EC4C-4BE6-A228-A05BE99AB4F2Q34300948-D62AFC9E-4D6E-40ED-AAE9-CEC2728E8764Q34480539-00437A6F-3A23-4CE3-B084-619E62CBADCFQ36497636-CCE35EE7-F26E-47AC-A082-193601B6F96BQ37737340-5E0FEAC4-AF97-4F81-9836-D286DA3A7A9BQ38656720-3F299AC3-E8E5-4747-9638-5A0BCDB99956Q39527847-075F9B13-FD1B-4A5C-BD7D-D801AC0AB74BQ39901918-82D92D2C-28AD-422A-AF43-FEEA5C6F2EB9Q40272138-1576120F-6FC7-486B-814D-0AD9C53029BFQ41772742-88FC7B9B-3E05-42F7-9075-AE64F6B7B8E2Q41863126-209523C2-122A-4AA0-B60A-7E02A0047D0BQ42147683-75E605C4-DD8C-4EAF-A8D8-E88B296FDD6FQ42610870-152F096E-FD31-44B8-A0E6-8A2CC7BA9F34Q42696995-D4A9C7A4-2165-4632-A704-DF402B7D228DQ50090665-32190EA2-D1CA-423F-9A53-82C344E9D554Q50976982-3CEADF87-2974-43F7-897E-C76578944ED6Q50996466-E06ADC40-E3B7-410E-AA1E-1679E48C3B45Q51150794-6F0BA78F-9744-4E25-A1B7-95A24A50E29CQ51350066-66336112-1780-4CE7-A06C-F12ACF766EEAQ51918803-9C6B69DE-6F22-41E3-A1EE-476CECD07645Q52967586-ED5C3F58-3503-4028-9F31-C5C9893AD9DBQ56776020-E9F9CDBB-1F28-44C5-9A01-D3EB235DBD8C
P2860
Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Clinical evaluation and verifi ...... ent planning system hyperplan.
@en
Clinical evaluation and verifi ...... ent planning system hyperplan.
@nl
type
label
Clinical evaluation and verifi ...... ent planning system hyperplan.
@en
Clinical evaluation and verifi ...... ent planning system hyperplan.
@nl
prefLabel
Clinical evaluation and verifi ...... ent planning system hyperplan.
@en
Clinical evaluation and verifi ...... ent planning system hyperplan.
@nl
P2093
P1476
Clinical evaluation and verifi ...... ent planning system hyperplan.
@en
P2093
Deuflhard P
Gellermann J
Stalling D
P304
P356
10.1016/S0360-3016(00)00425-9
P407
P577
2000-07-01T00:00:00Z